Royal Bank of Canada
ORKA

Royal Bank of Canada’s Oruka Therapeutics ORKA Stock Holding History

Royal Bank of Canada’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
11,123
+7,951
+251% +$530K ﹤0.01% 3776
2026
Q1 		$155K Buy
3,172
+2,033
+178% +$70.7K ﹤0.01% 4866
2025
Q4 		$34K Buy
1,139
+365
+47% +$10.2K ﹤0.01% 5768
2025
Q3 		$14K Sell
774
-1,730
-69% -$25.6K ﹤0.01% 6373
2025
Q2 		$27K Buy
2,504
+2,494
+24,940% +$26K ﹤0.01% 6168
2025
Q1 		$0 Sell
10
-45
-82% -$561 ﹤0.01% 7322
2024
Q4 		$1K Buy
+55
New +$1.34K ﹤0.01% 6827
2024
Q3 		– Sell
-3
Closed – – 7585
2024
Q2 		$0 Sell
3
-2
-40% -$80 ﹤0.01% 7633
2024
Q1 		$0 Hold
5
– – ﹤0.01% 7707
2023
Q4 		$0 Hold
5
– – ﹤0.01% 7674
2023
Q3 		$0 Sell
5
-17
-77% -$416 ﹤0.01% 7696
2023
Q2 		$1K Buy
+22
New +$542 ﹤0.01% 7108
2018
Q2 		– Hold
0
– – – 6817
2018
Q1 		– Hold
0
– – – 6861
2017
Q4 		– Hold
0
– – – 6952
2017
Q3 		– Hold
0
– – – 7032
2017
Q2 		– Hold
0
– – – 6807
2014
Q2 		– Hold
0
– – – 6171
2014
Q1 		– Hold
0
– – – 6188

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Royal Bank of Canada's ORKA Position: Q2 2026 in Review

Royal Bank of Canada increased its Oruka Therapeutics (ORKA) stake by 251% in Q2 2026, buying an estimated $530K and bringing the position to 11,123 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #3776.

Royal Bank of Canada first reported a position in ORKA in Q2 2023 and has held it in 12 quarters since. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Royal Bank of Canada held 11,123 shares of Oruka Therapeutics worth $1.06M as of Q2 2026.
  • Royal Bank of Canada bought 7,951 Oruka Therapeutics shares in Q2 2026, an estimated $530K.
  • Oruka Therapeutics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #3776 holding.
  • Royal Bank of Canada first reported a position in Oruka Therapeutics in Q2 2023 and has held it in 12 quarters since.
  • 256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.